Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000529510-2018-05-01T00:00:00Z",
    "date": "2018-05-01T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000529510",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-40",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Hazel Johnstone",
                "email": "hazel.johnstone@nhs.net",
                "telephone": "+44 1698794561",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-70",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Patrick Mulraney",
                "email": "pmulraney@nhs.net",
                "telephone": "+44 1698794471",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-70"
    },
    "tender": {
        "id": "NP47518",
        "title": "Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin",
        "description": "This framework agreement is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 2244011,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "tenderPeriod": {
            "endDate": "2018-03-12T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2018-03-12T12:00:00Z"
        },
        "documents": [
            {
                "id": "FEB309513",
                "documentType": "contractNotice",
                "title": "Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin",
                "description": "This framework is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland. The Authority intends awarding a single-supplier framework agreement on a line by line basis. Full details can be found within the ITT.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB309513",
                "format": "text/html"
            },
            {
                "id": "MAY318193",
                "documentType": "awardNotice",
                "title": "Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin",
                "description": "This framework agreement is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY318193",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "This framework is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland. The Authority has awarded a single-supplier framework agreement on a line by line basis.",
                "status": "complete",
                "value": {
                    "amount": 2244011,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 450
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "Option to extend by a further two (2) periods of up to twelve (12) months each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                }
            }
        ],
        "bidOpening": {
            "date": "2018-03-12T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
                    "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false
    },
    "language": "EN",
    "description": "The estimated value referred to in Section II.I.7 and V.2.4 covers the initial fifteen (15) months contract duration and the two (2) x twelve (12) month extension periods of the framework agreement. Further details of the lines awarded to each of the listed Framework Participants can be obtained using the contact details at the head of this notice. (SC Ref:540694)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000529510"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000529510"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP47518",
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP47518",
            "awardID": "NP47518",
            "status": "active",
            "dateSigned": "2018-04-04T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2018/S 028-060408"
        }
    ]
}